2022 American Transplant Congress
Safety and Efficacy of Early Central Line Removal in Post Liver Transplant Patients
*Purpose: Avoiding central line-associated infections (CLABSIs) is paramount in liver transplant recipients. As a hospital-wide infection control initiative at our institution, early removal of central…2022 American Transplant Congress
PACAP-Mediated Autophagy Prevents Liver Ischemia Reperfusion Injury in OLT
UCLA Medical Center, Los Angeles, CA
*Purpose: Pituitary adenylate cyclase-activating polypeptide (PACAP) is from vasoactive intestinal peptide-glucagon-secretin family. Our group was the first to demonstrate that neuropeptide PACAP, which innervates the…2022 American Transplant Congress
A Successful Expansion of Donor Liver Supply is Feasible with the Selective Use of Older DCD Livers
Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
*Purpose: DCD are a key way to expand the donor pool, yet many centers are hesitant about using anything but the most favorable DCD allografts,…2022 American Transplant Congress
Race Inequity in Liver Transplant Waitlisting: Effect Modification by Psychosocial Factors and the Stanford Integrated Psychosocial Assessment for Transplant
*Purpose: Race inequity in liver transplantation (LT) has been a longstanding area of injustice within the field of hepatology. Information from psychosocial evaluations and The…2022 American Transplant Congress
Liver Transplantation Outcomes for Budd-Chiari Syndrome in the MELD Era
*Purpose: Budd Chiari syndrome (BCS) has a heterogeneous clinical presentations ranging from asymptomatic cases to fulminant liver failure with significant morbidly and mortality. Recent data…2022 American Transplant Congress
Improving Access and Equity for Transplant: A Single-Center Experience
*Purpose: Many Hispanic Americans have misconceptions about transplantation due to language and cultural differences, which can make them less likely to undergo liver transplant (LT)…2022 American Transplant Congress
Racial/Ethnic Disparities in Rates of Living Donor Liver Transplant Are Partly Explained by Socioeconomic Deprivation in Adults
Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Living donor liver transplant (LDLT) is an important strategy for addressing the deceased donor liver shortage and is associated with improved survival but represents…2022 American Transplant Congress
Pretransplant Rifaximin Treatment Improves Liver Transplant Outcomes in Mice and Humans
UCLA Medical Center, Los Angeles, CA
*Purpose: We recently reported modifications of the gut microbiota by amoxicillin influences liver allograft function. Rifaximin (RFX), a nonabsorbable oral antimicrobial agent with a low…2022 American Transplant Congress
Analysis of Tissue and Effluent Damage Associated Molecular Patterns Following Hypothermic Oxygenated Machine Perfusion vs Static Cold Storage in Liver Transplantation
Transplant Surgery, Rutgers New Jersey Medical School, Newark, NJ
*Purpose: Hypothermic Oxygenated Machine Perfusion (HMP-O2) results in decreased ischemia/reperfusion injury (IRI) after liver transplantation; however, the molecular pathways of protection are largely unexplored. In…2022 American Transplant Congress
Early Experiences with Developing the Techniques of Pure Laparoscopic Explant Hepatectomy without Fragmentation in Living Donor Liver Transplantation
*Purpose: Minimally invasive surgery is increasingly performed in liver surgery including even donor hepatectomy. However, the development of minimally invasive techniques in liver transplantation has…
- 1
- 2
- 3
- …
- 180
- Next Page »